STEP Stock Analysis: Stepstone | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 6.181m USD | 12M Return: -22.1% | US85914M1071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.2M
EPS Trend: 94.1%
Qual. Beats: 1
Rev. Trend: 98.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 6.1 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
StepStone Group Inc. (NASDAQ: STEP) is a global private equity and venture capital firm founded in 2007 and headquartered in New York. It invests across multiple strategies, including primary fund commitments, direct investments, fund-of-funds, and secondary transactions (both direct and indirect), with a global focus spanning the United States, Europe, Asia, the Americas, and select emerging markets.
The firm targets a broad range of investment stages-from seed and early venture through growth capital, mezzanine, distressed, and buyout-across sectors such as technology, healthcare, financials, infrastructure, real estate, energy, consumer, and industrials. It allocates between 5% and 40% of its investments to emerging markets and considers both minority and majority equity stakes, co-investments, and follow-on opportunities.
As an asset manager in the Financials sector, StepStone operates in the private markets industry, which typically generates revenue through management fees on committed or invested capital and performance-based fees (such as carried interest) tied to investment returns. The firm went public in September 2020 and maintains additional offices across North America, South America, Europe, Asia, and Australia.
- Fee-related earnings expand as AUM scales past $200B
- Private wealth channel fuels retail and advisor net inflows
- Capital return accelerates through buybacks and dividend hikes
| Net Income: -318.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -9.19 > 1.0 |
| NWC/Revenue: -127.4% < 20% (prev 27.55%; Δ -155.0% < -1%) |
| CFO/TA -0.09 > 3% & CFO -814.1m > Net Income -318.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.3m) vs 12m ago 4.75% < -2% |
| Gross Margin: 52.31% > 18% (prev 6.52%; Δ 45.78% > 0.5%) |
| Asset Turnover: 31.90% > 50% (prev 28.79%; Δ 3.11% > 0%) |
| Interest Coverage Ratio: -8.28 > 6 (EBIT TTM -309.8m / Interest Expense TTM 37.4m) |
| A: -0.32 (Total Current Assets 548.7m - Total Current Liabilities 3.51b) / Total Assets 9.26b |
| B: -0.13 (Retained Earnings -1.18b / Total Assets 9.26b) |
| C: -0.04 (EBIT TTM -309.8m / Avg Total Assets 7.29b) |
| D: -0.08 (Book Value of Equity -637.6m / Total Liabilities 7.70b) |
| Altman-Z'' = -2.89 = D |
| DSRI: 0.10 (Receivables 250.4m/1.93b, Revenue 2.33b/1.54b) |
| GMI: 0.12 (GM 6.52% / 52.31%) |
| AQI: 1.68 (AQ_t 0.93 / AQ_t-1 0.55) |
| SGI: 1.52 (Revenue 2.33b / 1.54b) |
| TATA: 0.05 (NI -318.3m - CFO -814.1m) / TA 9.26b) |
| Beneish M = -3.78 (Cap -4..+1) = AAA |
As of November 17, 2026, the stock is trading at USD 45.59 with a total of 864,206 shares traded. Over the past week, the price has changed by -7.19%, over one month by +9.49%, over three months by -4.95% and over the past year by -22.12%.
Current recommended Stop Loss: 42.20 (which is 7.4% or 1.4 ATR below the current price).
Stepstone has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy STEP.
- StrongBuy: 6
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 65.6 | 43.9% |
P/E Forward = 19.1939
P/S = 2.6562
P/B = 33.0017
Revenue TTM = 2.33b USD
EBIT TTM = -309.8m USD
EBITDA TTM = -264.3m USD
Long Term Debt = 1.57b USD (from longTermDebt, last quarter)
Short Term Debt = 115.0m USD (from shortLongTermDebt, last quarter)
Debt = 1.84b USD (corrected: LT Debt 1.57b + ST Debt 115.0m) + Leases 162.5m
Net Debt = 1.55b USD (calculated: Debt 1.84b - CCE 297.0m)
Enterprise Value = 7.73b USD (6.18b + Debt 1.84b - CCE 297.0m)
Interest Coverage Ratio = -8.28 (Ebit TTM -309.8m / Interest Expense TTM 37.4m)
EV/FCF = -9.45x (Enterprise Value 7.73b / FCF TTM -817.6m)
FCF Yield = -10.58% (FCF TTM -817.6m / Enterprise Value 7.73b)
FCF Margin = -35.13% (FCF TTM -817.6m / Revenue TTM 2.33b)
Net Margin = -13.68% (Net Income TTM -318.3m / Revenue TTM 2.33b)
Gross Margin = 52.31% ((Revenue TTM 2.33b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 53.59% (prev 43.80%)
Tobins Q-Ratio = 0.83 (Enterprise Value 7.73b / Total Assets 9.26b)
Interest Expense / Debt = 2.03% (Interest Expense 37.4m / Debt 1.84b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -244.8m (EBIT -309.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.16 (Total Current Assets 548.7m / Total Current Liabilities 3.51b)
Debt / Equity = -2.89 (negative equity) (Debt 1.84b / totalStockholderEquity, last quarter -637.6m)
Debt / EBITDA = -5.85 (negative EBITDA) (Net Debt 1.55b / EBITDA -264.3m)
Debt / FCF = -1.89 (negative FCF - burning cash) (Net Debt 1.55b / FCF TTM -817.6m)
Total Stockholder Equity = -492.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.36% (Net Income -318.3m / Total Assets 9.26b)
RoE = 64.65% (negative equity) (Net Income TTM -318.3m / Total Stockholder Equity -492.3m)
RoCE = -28.86% (EBIT -309.8m / Capital Employed (Equity -492.3m + L.T.Debt 1.57b))
RoIC = -4.27% (negative operating profit) (NOPAT -244.8m / Invested Capital 5.73b)
WACC = 9.10% (E(6.18b)/V(8.02b) * Re(11.34%) + D(1.84b)/V(8.02b) * Rd(2.03%) * (1-Tc(0.21)))
Discount Rate = 11.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.61 | Cagr: 8.43%
[DCF] Fair Price = unknown (Cash Flow -817.6m)
EPS Correlation: 94.15 | EPS CAGR: 29.71% | SUE: 0.99 | # QB: 1
Revenue Correlation: 98.62 | Revenue CAGR: 69.67% | SUE: 2.07 | # QB: 1
EPS current Quarter (2026-12-31): EPS=0.80 | Chg30d=+5.57% | Revisions=-12% | Analysts=9
EPS current Year (2027-03-31): EPS=2.56 | Chg30d=+3.45% | Revisions=+50% | GrowthEPS=+18.6% | GrowthRev=+25.5%
EPS next Year (2028-03-31): EPS=3.52 | Chg30d=+3.23% | Revisions=+0% | GrowthEPS=+37.3% | GrowthRev=+16.0%
[Analyst] Revisions Ratio: +12% (up=8, down=6)